268 related articles for article (PubMed ID: 33876228)
1. The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL.
Parikh SA; Rabe KG; Kay NE; Call TG; Ding W; Leis JF; Kenderian SS; Muchtar E; Wang Y; Koehler AB; Schwager SM; Lesnick CE; Kleinstern G; Van Dyke D; Hanson CA; Braggio E; Slager SL; Shanafelt TD
Blood; 2021 Jul; 138(2):149-159. PubMed ID: 33876228
[TBL] [Abstract][Full Text] [Related]
2. A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL).
Molica S; Giannarelli D; Levato L; Mirabelli R; Gentile M; Lentini M; Morabito F
Int J Hematol; 2014 Sep; 100(3):290-5. PubMed ID: 25064370
[TBL] [Abstract][Full Text] [Related]
3. Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines.
Call TG; Norman AD; Hanson CA; Achenbach SJ; Kay NE; Zent CS; Ding W; Cerhan JR; Rabe KG; Vachon CM; Hallberg EJ; Shanafelt TD; Slager SL
Cancer; 2014 Jul; 120(13):2000-5. PubMed ID: 24711224
[TBL] [Abstract][Full Text] [Related]
4. Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia.
Shanafelt TD; Kay NE; Rabe KG; Call TG; Zent CS; Maddocks K; Jenkins G; Jelinek DF; Morice WG; Boysen J; Schwager S; Bowen D; Slager SL; Hanson CA
J Clin Oncol; 2009 Aug; 27(24):3959-63. PubMed ID: 19620484
[TBL] [Abstract][Full Text] [Related]
5. Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis.
Kleinstern G; Boddicker NJ; O'Brien DR; Allmer C; Rabe KG; Norman AD; Griffin R; Yan H; Ma T; Call TG; Bruins L; Brown S; Bonolo de Campos C; Hanson CA; Leis JF; Ding W; Vachon CM; Kay NE; Oakes CC; Parker AS; Brander DM; Weinberg JB; Furman RR; Shanafelt TD; Cerhan JR; Parikh SA; Braggio E; Slager SL
Blood Adv; 2024 May; 8(9):2118-2129. PubMed ID: 38359367
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.
Rawstron AC; Bennett FL; O'Connor SJ; Kwok M; Fenton JA; Plummer M; de Tute R; Owen RG; Richards SJ; Jack AS; Hillmen P
N Engl J Med; 2008 Aug; 359(6):575-83. PubMed ID: 18687638
[TBL] [Abstract][Full Text] [Related]
7. Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis beyond the CLL international prognostic index.
Kleinstern G; O'Brien DR; Li X; Tian S; Kabat BF; Rabe KG; Norman AD; Yan H; Vachon CM; Boddicker NJ; Call TG; Parikh SA; Bruins L; Bonolo de Campos C; Leis JF; Shanafelt TD; Ding W; Cerhan JR; Kay NE; Slager SL; Braggio E
Am J Hematol; 2020 Aug; 95(8):906-917. PubMed ID: 32279347
[TBL] [Abstract][Full Text] [Related]
8. The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring.
Dagklis A; Fazi C; Sala C; Cantarelli V; Scielzo C; Massacane R; Toniolo D; Caligaris-Cappio F; Stamatopoulos K; Ghia P
Blood; 2009 Jul; 114(1):26-32. PubMed ID: 19029437
[TBL] [Abstract][Full Text] [Related]
9. Chronic Lymphocytic Leukemia Prognostic Index: A New Integrated Scoring System to Predict the Time to First Treatment in Chinese Patients with Chronic Lymphocytic Leukemia.
Li H; Yi SH; Xiong WJ; Liu HM; Lyu R; Wang TY; Liu W; Zhong SZ; Yu Z; Zou DH; Xu Y; An G; Li ZJ; Qiu LG
Chin Med J (Engl); 2017 Jan; 130(2):135-142. PubMed ID: 28091403
[TBL] [Abstract][Full Text] [Related]
10. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors.
Rossi D; Sozzi E; Puma A; De Paoli L; Rasi S; Spina V; Gozzetti A; Tassi M; Cencini E; Raspadori D; Pinto V; Bertoni F; Gattei V; Lauria F; Gaidano G; Forconi F
Br J Haematol; 2009 Jun; 146(1):64-75. PubMed ID: 19438485
[TBL] [Abstract][Full Text] [Related]
11. Circulating regulatory T cells in "clinical" monoclonal B-cell lymphocytosis.
D'Arena G; Rossi G; Minervini MM; Savino L; D'Auria F; Laurenti L; Del Principe MI; Deaglio S; Biagi A; De Martino L; De Feo V; Statuto T; Musto P; Del Poeta G
Int J Immunopathol Pharmacol; 2011; 24(4):915-23. PubMed ID: 22230398
[TBL] [Abstract][Full Text] [Related]
12. The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients.
Molica S; Shanafelt TD; Giannarelli D; Gentile M; Mirabelli R; Cutrona G; Levato L; Di Renzo N; Di Raimondo F; Musolino C; Angrilli F; Famà A; Recchia AG; Chaffee KG; Neri A; Kay NE; Ferrarini M; Morabito F
Am J Hematol; 2016 Nov; 91(11):1090-1095. PubMed ID: 27465919
[TBL] [Abstract][Full Text] [Related]
13. Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature.
Abdelbaky SB; Giacopelli B; Rabe KG; Yamaguchi K; Wu YZ; Yan H; Shanafelt TD; Parikh SA; Ding W; Hampel PJ; Brown S; Cerhan JR; Vachon CM; Kay NE; Hanson CA; Parker AS; Braggio E; Slager SL; Oakes CC
Blood; 2024 Apr; 143(17):1752-1757. PubMed ID: 38194687
[TBL] [Abstract][Full Text] [Related]
14. Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysis.
Molica S; Giannarelli D; Levato L; Gentile M; Mirabelli R; Morabito F
Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):e55-60. PubMed ID: 25445470
[TBL] [Abstract][Full Text] [Related]
15. Clinical presentation, progression, and outcome of patients with clonal B-cell counts of less than 5 × 10(9)/l, 5 to 10 × 10(9)/l, and more than 10 × 10(9)/l and chronic lymphocytic leukemia immunophenotype.
Foster AE; Nguyen TT; Al-Hammadi N; Frater JL; Hassan A; Kreisel F
Am J Clin Pathol; 2015 Jan; 143(1):70-7. PubMed ID: 25511144
[TBL] [Abstract][Full Text] [Related]
16. Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis.
Fung SS; Hillier KL; Leger CS; Sandhu I; Vickars LM; Galbraith PF; Li CH; Leitch HA
Leuk Lymphoma; 2007 Jun; 48(6):1087-91. PubMed ID: 17577771
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification.
Strati P; Shanafelt TD
Blood; 2015 Jul; 126(4):454-62. PubMed ID: 26065657
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of prognostic factors in asymptomatic patients with B-cell chronic lymphocytic leukemia-like lymphocytosis: the cut-off of 11 × 10(9)/L monoclonal lymphocytes better identifies subgroups with different outcomes.
Oliveira AC; Fernández de Sevilla A; Domingo A; De La Banda E; Domingo-Domènech E; Mercadal S; Ruiz-Xivillé N; Alonso E; Encuentra M; González-Barca E
Ann Hematol; 2015 Apr; 94(4):627-32. PubMed ID: 25471173
[TBL] [Abstract][Full Text] [Related]
19. Association of elevated serumfree light chains with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis.
Clay-Gilmour AI; Rishi AR; Goldin LR; Greenberg-Worisek AJ; Achenbach SJ; Rabe KG; Maurer MJ; Kay NE; Shanafelt TD; Call TG; Brice Weinberg J; Camp NJ; Cerhan JR; Leis J; Norman A; Murray DL; Vincent Rajkumar S; Caporaso NE; Landgren O; McMaster ML; Slager SL; Vachon CM
Blood Cancer J; 2019 Aug; 9(8):59. PubMed ID: 31383849
[TBL] [Abstract][Full Text] [Related]
20. Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL.
Vardi A; Dagklis A; Scarfò L; Jelinek D; Newton D; Bennett F; Almeida J; Rodriguez-Caballero A; Allgood S; Lanasa M; Cortelezzi A; Orlandi E; Veronese S; Montillo M; Rawstron A; Shanafelt T; Orfao A; Stamatopoulos K; Ghia P
Blood; 2013 May; 121(22):4521-8. PubMed ID: 23596047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
